Selected article for: "anticancer treatment phase and SARS infection"
Author: Hong-Yan Zhang; Lin-Wei Wang; Yuan-Yuan Chen; Xiao-Kun Shen; Qun Wang; You-Qin Yan; Yi Yu; Qiuji Wu; Xinghuan Wang; Ya-Hua Zhong; Melvin Chua Lee Kiang; Cong-Hua Xie
Title: A Multicentre Study of 2019 Novel Coronavirus Disease Outcomes of Cancer Patients in Wuhan, China
  • Document date: 2020_3_26
    • ID: 8rxjju0t_47
    Snippet: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03. 21.20037127 doi: medRxiv preprint hospital-acquired transmission was also an important way of infection in cancer patients. In addition, cancer patients are at a higher risk of COVID-19, even if they have completed the anticancer treatment. More than 60% (65.6%) of cancer patients in our study were at the follow-up phase after radical an.....
    Document: is the (which was not peer-reviewed) The copyright holder for this preprint . https://doi.org/10.1101/2020.03. 21.20037127 doi: medRxiv preprint hospital-acquired transmission was also an important way of infection in cancer patients. In addition, cancer patients are at a higher risk of COVID-19, even if they have completed the anticancer treatment. More than 60% (65.6%) of cancer patients in our study were at the follow-up phase after radical anticancer treatment. For regular anticancer treatment and follow up, cancer patients need to visit hospital frequently, which increases the risk of SARS-CoV-2 exposure and infection. Besides, cancer patients with COVID-19 might have more complications due to their old age, weakened immune system and the side effects of undergoing treatments. 12 14 Therefore, we recommend systemic screening should be conducted among hospitalized cancer patients. In our study, we also observed that ongoing anticancer treatment was interrupted in most patients because of the diagnosis of COVID-19. Fortunately, we had not observed tumour progression during the treatment of COVID-19 pneumonia. On one hand, appropriately delaying treatment and reductive frequency of visit hospital for cancer patients is feasible. On the other hand, medical oncologists are recommended to provide professional consultation for COVID-19 cancer patients to ensure essential anticancer treatments.

    Search related documents:
    Co phrase search for related documents
    • anticancer treatment and essential anticancer treatment: 1
    • anticancer treatment and follow phase: 1, 2, 3, 4
    • anticancer treatment and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20
    • anticancer treatment and immune system: 1, 2
    • anticancer treatment and ongoing anticancer treatment: 1, 2, 3, 4, 5
    • anticancer treatment and pneumonia treatment: 1, 2
    • anticancer treatment and SARS exposure: 1
    • anticancer treatment and tumour progression: 1
    • cancer patient and follow phase: 1
    • cancer patient and high risk: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25, 26, 27, 28, 29, 30, 31, 32, 33, 34, 35, 36, 37, 38, 39, 40, 41, 42, 43
    • cancer patient and hospital visit: 1, 2
    • cancer patient and immune system: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17
    • cancer patient and infection SARS exposure: 1
    • cancer patient and medical oncologist: 1, 2
    • cancer patient and old age: 1, 2, 3
    • cancer patient and pneumonia treatment: 1, 2, 3
    • cancer patient and SARS exposure: 1, 2, 3, 4, 5, 6
    • cancer patient and study cancer patient: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24
    • cancer patient and tumour progression: 1, 2, 3